Enterprise record
Alpha ID: alpha:company:b720a7d2-bfe6-459b-89ac-10b754d679aaVersion: public-1
17 published Claims8 sources
Governance record
Record overview
Explore Cabaletta Bio, Inc.'s published governance Claims, committee structure, and linked sources. Each item reflects the scope and dates of its source.
About this record →- Company
- Cabaletta Bio, Inc.
- Published Claims
- 17
- Evidence records
- 8
- Record version
- public-1
Committee overview
Committee summaries link to the published Claim and its source evidence.
| Committee | Disclosed mandate or composition |
|---|---|
| Audit | Chair: Richard Henriques, MBA · 2 listed members |
Key governance topics
Counts describe published Claims in this record.
Key Claims
- Leadership RoleCatherine Bollard, MBChB, M.D.: DirectorCabaletta Bio, Inc. DEF 14A 2025-05-13
- Leadership RoleMark Simon, MBA: Director, AuditCabaletta Bio, Inc. DEF 14A 2025-05-13
- Leadership RoleRichard Henriques, MBA: Director, Audit · ChairCabaletta Bio, Inc. DEF 14A 2025-05-13
- Leadership RoleScott Brun, M.D.: DirectorCabaletta Bio, Inc. DEF 14A 2025-05-13
Board and committees
Financial statements
Published financial observations retain their reported values, periods, and sources. Coverage may be partial; this is not a reconstructed complete financial statement.
All financials coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageControl and shareholders
Control and shareholders coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageCompensation
Compensation coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageAuditors, advisors and reporting
Auditors, advisors and reporting coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageLegal
Legal coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageAI governance
AI governance coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageEvidence, history and coverage
Additional published Claims
Published evidence records
8 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.
Alpha canonical company public projection
canonical identity · Source published: Date unavailable · Retrieved: Oct 5, 2026
Supports 3 claims
- Legal Name: Cabaletta Bio, Inc. · Claim reviewed: Oct 5, 2026
- Entity Status: Public listing published · Claim reviewed: Oct 5, 2026
- Published Fact: US · Claim reviewed: Oct 5, 2026
Cabaletta Bio, Inc. DEF 14A 2025-05-13
sec proxy · Source published: May 13, 2025 · Retrieved: Apr 28, 2026
Supports 6 claims
- Leadership Role: Catherine Bollard, MBChB, M.D.: Director · Claim reviewed: Oct 5, 2026
- Leadership Role: Mark Simon, MBA: Director, Audit · Claim reviewed: Oct 5, 2026
- Leadership Role: Richard Henriques, MBA: Director, Audit · Chair · Claim reviewed: Oct 5, 2026
- Leadership Role: Scott Brun, M.D.: Director · Claim reviewed: Oct 5, 2026
- Leadership Role: Shawn Tomasello, MBA: Director · Claim reviewed: Oct 5, 2026
- Leadership Role: Steven Nichtberger, M.D.: Director · Claim reviewed: Oct 5, 2026
CABA DEF 14A executive officers
sec filing · Source published: Apr 28, 2026 · Retrieved: May 16, 2026
Supports 1 claim
- Leadership Role: Anup Marda: Chief Financial Officer · Claim reviewed: Oct 5, 2026
CABA DEF 14A executive officers
sec filing · Source published: Apr 28, 2026 · Retrieved: May 16, 2026
Supports 1 claim
- Leadership Role: Arun Das, M.D.: Chief Business Officer · Claim reviewed: Oct 5, 2026
CABA DEF 14A executive officers
sec filing · Source published: Apr 28, 2026 · Retrieved: May 16, 2026
Supports 1 claim
- Leadership Role: Michael Gerard: General Counsel and Secretary · Claim reviewed: Oct 5, 2026
CABA DEF 14A executive officers
sec filing · Source published: Apr 28, 2026 · Retrieved: May 16, 2026
Supports 1 claim
- Leadership Role: Steve Gavel: Chief Commercial Officer · Claim reviewed: Oct 5, 2026
CABA DEF 14A executive officers
sec filing · Source published: Apr 28, 2026 · Retrieved: May 16, 2026
Supports 1 claim
- Leadership Role: Steven Nichtberger, M.D.: Chief Executive Officer and President · Claim reviewed: Oct 5, 2026
Audit
board seats · Source published: Date unavailable · Retrieved: Date unavailable
Supports 3 claims
- Committee Record: Audit: Chair Richard Henriques, MBA; Members Richard Henriques, MBA (Chair); Mark Simon, MBA · Claim reviewed: Oct 5, 2026
- Committee Appointment: Richard Henriques, MBA: chair, Audit · Claim reviewed: Oct 5, 2026
- Committee Appointment: Mark Simon, MBA: member, Audit · Claim reviewed: Oct 5, 2026
No published record changes are available in this projection.
Identity
unclaimed
Evidence
source reported
Evaluation
Unknown
Monitoring
Unknown
Authority
Unknown
Freshness
Observed 2026-10-05
- Board and committees
- published
- Financial statements
- not observed
- Control and shareholders
- not observed
- Compensation
- not observed
- Auditors, advisors and reporting
- not observed
- Legal
- not observed
- AI governance
- not observed